Verfügbarkeit: Impfratgeber | Technische Universität München

Gespeichert in:

Bibliographische Detailangaben
Beteilige Person:	Heininger, Ulrich 1961- (VerfasserIn)
Format:	Buch
Sprache:	Deutsch
Veröffentlicht:	Bremen ; London UNI-MED Verlag AG [2022]
Ausgabe:	11. Auflage
Schriftenreihe:	UNI-MED science
Schlagwörter:	Impfung Impfratgeber STIKO Impfungen
Links:	http://deposit.dnb.de/cgi-bin/dokserv?id=6e8e3031fb4340b69aede87c4ee953a1&prov=M&dok_var=1&dok_ext=htm https://d-nb.info/1279632488/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034157189&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
Umfang:	170 Seiten Illustrationen, Karten 25 cm, 468 g
ISBN:	9783837416411 3837416410

Internformat

MARC


LEADER	00000nam a2200000 c 4500
001	BV048892626
003	DE-604
005	20240219
007	t\|
008	230406s2022 gw a\|\|\| \|\|\|\| 00\|\|\| ger d
015			\|a 23,N06 \|2 dnb
015			\|a 23,A15 \|2 dnb
016	7		\|a 1279632488 \|2 DE-101
020			\|a 9783837416411 \|c Festeinband : EUR 39.80 (DE), EUR 41.00 (AT), CHF 66.00 (freier Preis) \|9 978-3-8374-1641-1
020			\|a 3837416410 \|9 3-8374-1641-0
024	3		\|a 9783837416411
035			\|a (OCoLC)1369264089
035			\|a (DE-599)DNB1279632488
040			\|a DE-604 \|b ger \|e rda
041	0		\|a ger
044			\|a gw \|c XA-DE
049			\|a DE-578 \|a DE-19 \|a DE-355
082	0	4	\|a 614.47 \|2 23/ger
084			\|a XD 3303 \|0 (DE-625)152554:12909 \|2 rvk
084			\|a WA 115 \|2 nlm
084			\|a QW 806 \|2 nlm
084			\|8 1\p \|a 610 \|2 23sdnb
100	1		\|a Heininger, Ulrich \|d 1961- \|e Verfasser \|0 (DE-588)128881313 \|4 aut
245	1	0	\|a Impfratgeber \|b Impfempfehlungen für Kinder, Jugendliche und Erwachsene : unter Berücksichtigung des Infektionsschutzgesetzes \|c Prof. Dr. Ulrich Heininger
250			\|a 11. Auflage
264		1	\|a Bremen ; London \|b UNI-MED Verlag AG \|c [2022]
264		4	\|c © 2022
300			\|a 170 Seiten \|b Illustrationen, Karten \|c 25 cm, 468 g
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
490	0		\|a UNI-MED science
650	0	7	\|a Impfung \|0 (DE-588)4026656-4 \|2 gnd \|9 rswk-swf
653			\|a Impfratgeber
653			\|a STIKO
653			\|a Impfungen
689	0	0	\|a Impfung \|0 (DE-588)4026656-4 \|D s
689	0		\|5 DE-604
710	2		\|a UNI-MED Verlag AG \|0 (DE-588)1065561733 \|4 pbl
780	0	0	\|i Vorangegangen ist \|z 9783837415704
856	4	2	\|m X:MVB \|q text/html \|u http://deposit.dnb.de/cgi-bin/dokserv?id=6e8e3031fb4340b69aede87c4ee953a1&prov=M&dok_var=1&dok_ext=htm \|3 Inhaltstext
856	4	2	\|m B:DE-101 \|q application/pdf \|u https://d-nb.info/1279632488/04 \|3 Inhaltsverzeichnis
856	4	2	\|m DNB Datenaustausch \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034157189&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
883	2		\|8 1\p \|a dnb \|d 20230404 \|q DE-101 \|u https://d-nb.info/provenance/plan#dnb
943	1		\|a oai:aleph.bib-bvb.de:BVB01-034157189

Datensatz im Suchindex

DE-BY-UBR_call_number	91/XD 3303 H468(11)
DE-BY-UBR_katkey	6773078
DE-BY-UBR_location	UB Lesesaal Medizin
DE-BY-UBR_media_number	069042193385
_version_	1835096824095965184
adam_text	INHALTSVERZEICHNIS YY GESCHICHTE DES IMPFWESENS 13 YY ALLGEMEINE GRUNDLAGEN 20 2.1. IMMUNOLOGISCHE GRUNDLAGEN ...................................................................................................................20 2.1.1. ANGEBORENE IMMUNITAET ................................................................................................................................ 20 2.1.2. ADAPTIVE IMMUNITAET ..................................................................................................................................... 20 2.2. PASSIVE IMMUNISIERUNG .............................................................................................................................. 21 2.2.1. DEFINITION ..................................................................................................................................................... 21 2.2.2. HERSTELLUNG UND INDIKATIONEN ...................................................................................................................... 21 2.2.3. ANWENDUNG, WIRKUNGSDAUER UND VERTRAEGLICHKEIT ....................................................................................... 23 2.3. AKTIVE IMMUNISIERUNG ...............................................................................................................................24 2.3.1. LEBENDIMPFSTOFFE ........................................................................................................................................ 25 2.3.2. INAKTIVIERTE IMPFSTOFFE ( TOTIMPFSTOFFE ) ...................................................................................................... 25 2.3.3. MRNA UND VEKTORBASIERTE DNA-IMPFSTOFFE ................................................................................................. 25 2.4. SIMULTANIMPFUNGEN ................................................................................................................................... 25 2.5. ZEITABSTAENDE ZWISCHEN IMPFUNGEN ......................................................................................................... 26 2.5.1. ZEITABSTAENDE INNERHALB EINER IMPFSERIE ...................................................................................................... 26 2.5.2. ZEITABSTAENDE ZWISCHEN VERSCHIEDENEN IMPFSTOFFEN .................................................................................... 26 2.6. WIRKSAMKEIT UND VERTRAEGLICHKEIT VON IMPFUNGEN .................................................................................. 27 2.6.1. WIRKSAMKEIT .................................................................................................................................................. 27 2.6.2. VERTRAEGLICHKEIT ............................................................................................................................................. 28 2.7. IMPFTECHNIKEN ............................................................................................................................................ 30 YY FORMALE GRUNDLAGEN UND LOGISTIK 34 3.1. IMPFSTOFFHERSTELLUNG ................................................................................................................................... 34 3.2. PRUEFUNG UND ZULASSUNG VON IMPFSTOFFEN ................................................................................................ 34 3.3. UNTERSUCHUNG, AUFKLAERUNG UND BERATUNG DES IMPFLINGS .......................................................................36 3.4. ABKLAERUNG VON IMPFNEBENWIRKUNGEN ..................................................................................................... 38 3.5. IMPFDOKUMENTATION .................................................................................................................................. 41 3.6. AUFBEWAHRUNG VON IMPFSTOFFEN ............................................................................................................. 42 3.7. LIEFERENGPAESSE ........................................................................................................................................... 42 3.8. IMPFEMPFEHLUNGEN IN DEUTSCHLAND, OESTERREICH UND DER SCHWEIZ ........................................................ 43 3.9. KOMBINIERTE IMPFUNGEN - KOMBINATIONSIMPFSTOFFE .............................................................................. 47 YY ALLGEMEIN EMPFOHLENE IMPFUNGEN FUER KINDER UND JUGENDLICHE 49 4.1. DIPHTHERIE .................................................................................................................................................. 49 4.1.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................. 49 4.1.2. KRANKHEITSBILD UND DIAGNOSE ...................................................................................................................... 50 4.1.3. THERAPIE ....................................................................................................................................................... 51 4.1.4. PRAEVENTION .................................................................................................................................................... 51 4.1.4.1. CHEMOPROPHYLAXE ........................................................................................................................................ 51 4.1.4.2. IMPFUNG ....................................................................................................................................................... 51 4.2. TETANUS ....................................................................................................................................................... 53 4.2.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 53 4.2.2. KRANKHEITSBILD UND DIAGNOSE ...................................................................................................................... 53 INHALTSVERZEICHNIS 9 4.2.3. THERAPIE ...................................................................................................................................................... 54 4.2.4. PRAEVENTION ................................................................................................................................................... 54 4.2.4.1 . CHEMOPROPHYLAXE ........................................................................................................................................ 54 4.2.4.2. IMPFUNG ...................................................................................................................................................... 54 4.3. PERTUSSIS (KEUCHHUSTEN) ........................................................................................................................... 57 4.3.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 57 4.3.2. KRANKHEITSBILD UND DIAGNOSE ...................................................................................................................... 59 4.3.3. THERAPIE ...................................................................................................................................................... 60 4.3.4. PRAEVENTION ................................................................................................................................................... 60 4.3.4.1 . CHEMOPROPHYLAXE ........................................................................................................................................ 60 4.3.4.2. IMPFUNG ...................................................................................................................................................... 60 4.4. POLIOMYELITIS (KINDERLAEHMUNG) ................................................................................................................. 66 4.4.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 66 4.4.2. KRANKHEITSBILD UND DIAGNOSE ...................................................................................................................... 67 4.4.3. THERAPIE ...................................................................................................................................................... 68 4.4.4. PRAEVENTION ................................................................................................................................................... 68 4.4.4.1. CHEMOPROPHYLAXE ........................................................................................................................................ 68 4.4.4.2. IMPFUNG ...................................................................................................................................................... 68 4.5. HAEMOPHILUS-INFLUENZAE-TYP-B-LNFEKTIONEN ........................................................................................... 71 4.5.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 71 4.5.2. KRANKHEITSBILD UND DIAGNOSE ...................................................................................................................... 72 4.5.3. THERAPIE ...................................................................................................................................................... 73 4.5.4. PRAEVENTION ................................................................................................................................................... 73 4.5.4.1 . CHEMOPROPHYLAXE ........................................................................................................................................ 73 4.5.4.2. IMPFUNG ...................................................................................................................................................... 74 4.6. HEPATITIS B .................................................................................................................................................. 75 4.6.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 75 4.6.2. KRANKHEITSBILD UND DIAGNOSE ...................................................................................................................... 76 4.6.3. THERAPIE ...................................................................................................................................................... 77 4.6.4. PRAEVENTION ................................................................................................................................................... 77 4.6.4.1 . CHEMOPROPHYLAXE ....................................................................................................................................... 77 4.6.4.2. IMPFUNG ...................................................................................................................................................... 77 4.7. ROTAVIRUS ..................................................................................................................................................... 81 4.7.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 81 4.7.2. KRANKHEITSBILD UND DIAGNOSE ...................................................................................................................... 82 4.7.3. THERAPIE ...................................................................................................................................................... 82 4.7.4. PRAEVENTION ................................................................................................................................................... 82 4.7.4.1 . ALLGEMEINE PROPHYLAXE ............................................................................................................................... 82 4.7.4.2. IMPFUNG ...................................................................................................................................................... 83 4.8. PNEUMOKOKKEN-KRANKHEITEN ................................................................................................................... 84 4.8.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 84 4.8.2. KRANKHEITSBILD UND DIAGNOSE ...................................................................................................................... 85 4.8.3. THERAPIE ...................................................................................................................................................... 85 4.8.4. PROPHYLAXE ................................................................................................................................................... 86 4.8.4.1 . CHEMOPROPHYLAXE ....................................................................................................................................... 86 4.8.4.2. IMPFUNG ...................................................................................................................................................... 86 4.9. MENINGOKOKKEN-KRANKHEITEN .................................................................................................................. 91 4.9.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 91 4.9.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 93 4.9.3. THERAPIE ...................................................................................................................................................... 93 4.9.4. PROPHYLAXE ................................................................................................................................................... 93 4.9.4.1 . CHEMOPROPHYLAXE ....................................................................................................................................... 93 4.9.4.2. IMPFUNG ...................................................................................................................................................... 93 10 INHALTSVERZEICHNIS 4.10. MASERN .........................................................................................................................................................98 4.10.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 98 4.10.2. KRANKHEITSBILD UND DIAGNOSE ...................................................................................................................... 99 4.10.3. THERAPIE ..................................................................................................................................................... 101 4.10.4. PRAEVENTION .................................................................................................................................................. 101 4.10.4.1. CHEMOPROPHYLAXE ..................................................................................................................................... 101 4.10.4.2. IMPFUNG ..................................................................................................................................................... 101 4.11. MUMPS ...................................................................................................................................................... 105 4.11.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE .............................................................................................. 105 4.11.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 105 4.11.3. THERAPIE ..................................................................................................................................................... 106 4.11.4. PROPHYLAXE .................................................................................................................................................. 106 4.11.4.1. CHEMOPROPHYLAXE ..................................................................................................................................... 106 4.11.4.2. IMPFUNG ...................................................................................................................................................... 106 4.12. ROETELN ........................................................................................................................................................ 107 4.12.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE .............................................................................................. 107 4.12.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 108 4.12.3. THERAPIE ..................................................................................................................................................... 109 4.12.4. PROPHYLAXE .................................................................................................................................................. 109 4.12.4.1. CHEMOPROPHYLAXE ..................................................................................................................................... 109 4.12.4.2. IMPFUNG ...................................................................................................................................................... 109 4.13. VARIZELLEN (WINDPOCKEN) ........................................................................................................................ 111 4.13.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE .............................................................................................. 111 4.13.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 112 4.13.3. THERAPIE ..................................................................................................................................................... 113 4.13.4. PROPHYLAXE .................................................................................................................................................. 113 4.13.4.1. CHEMOPROPHYLAXE ..................................................................................................................................... 113 4.13.4.2. IMPFUNG ...................................................................................................................................................... 113 4.13.4.3. HERPES-ZOSTER-IMPFUNG ............................................................................................................................. 117 4.14. HUMANPATHOGENE PAPILLOMAVIREN (HPV) ............................................................................................... 119 4.14.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE .............................................................................................. 119 4.14.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 120 4.14.3. THERAPIE ..................................................................................................................................................... 120 4.14.4. PRAEVENTION .................................................................................................................................................. 120 4.14.4.1. ALLGEMEINE PROPHYLAXE ............................................................................................................................... 120 4.14.4.2. IMPFUNG ...................................................................................................................................................... 120 YY INDIKATIONS UND REISEIMPFUNGEN FUER KINDER UND JUGENDLICHE 124 5.1. TUBERKULOSE .............................................................................................................................................. 124 5.1.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE .............................................................................................. 124 5.1.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 125 5.1.3. THERAPIE ..................................................................................................................................................... 126 5.1.4. PROPHYLAXE .................................................................................................................................................. 127 5.1.4.1. CHEMOPROPHYLAXE ..................................................................................................................................... 127 5.1.4.2. IMPFUNG ...................................................................................................................................................... 127 5.2. INFLUENZA (GRIPPE) ..................................................................................................................................... 128 5.2.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE .............................................................................................. 128 5.2.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 130 5.2.3. THERAPIE ...................................................................................................................................................... 130 5.2.4. PROPHYLAXE ................................................................................................................................................... 131 5.2.4.1. CHEMOPROPHYLAXE ..................................................................................................................................... 131 5.2.4.2. IMPFUNG ...................................................................................................................................................... 131 INHALTSVERZEICHNIS 11 5.3. HEPATITIS A ................................................................................................................................................. 134 5.3.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 134 5.3.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 135 5.3.3. THERAPIE ..................................................................................................................................................... 135 5.3.4. PROPHYLAXE .................................................................................................................................................. 135 5.3.4.1. CHEMOPROPHYLAXE ..................................................................................................................................... 135 5.3.4.2. IMPFUNG ...................................................................................................................................................... 135 5.4. FRUEHSOMMER-MENINGOENZEPHALITIS (FSME) ........................................................................................... 137 5.4.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 137 5.4.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 138 5.4.3. THERAPIE ..................................................................................................................................................... 140 5.4.4. PROPHYLAXE .................................................................................................................................................. 140 5.4.4.1. CHEMOPROPHYLAXE ..................................................................................................................................... 140 5.4.4.2. IMPFUNG ...................................................................................................................................................... 140 5.5. TYPHUS ...................................................................................................................................................... 142 5.5.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 142 5.5.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 143 5.5.3. THERAPIE ..................................................................................................................................................... 143 5.5.4. PROPHYLAXE .................................................................................................................................................. 143 5.5.4.1. CHEMOPROPHYLAXE ..................................................................................................................................... 143 5.5.4.2. IMPFUNG ..................................................................................................................................................... 144 5.6. CHOLERA ...................................................................................................................................................... 145 5.6.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 145 5.6.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 145 5.6.3. THERAPIE ..................................................................................................................................................... 145 5.6.4. PROPHYLAXE .................................................................................................................................................. 146 5.6.4.1 . CHEMOPROPHYLAXE ..................................................................................................................................... 146 5.6.4.2. IMPFUNG ...................................................................................................................................................... 146 5.7. TOLLWUT (RABIES) ........................................................................................................................................ 147 5.7.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 147 5.7.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 147 5.7.3. THERAPIE ..................................................................................................................................................... 148 5.7.4. PROPHYLAXE .................................................................................................................................................. 148 5.7.4.1. CHEMOPROPHYLAXE ..................................................................................................................................... 148 5.7.4.2. IMPFUNG ..................................................................................................................................................... 148 5.8. GELBFIEBER ................................................................................................................................................. 149 5.8.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 149 5.8.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 150 5.8.3. THERAPIE ..................................................................................................................................................... 150 5.8.4. PROPHYLAXE .................................................................................................................................................. 150 5.8.4.1 . CHEMOPROPHYLAXE ..................................................................................................................................... 150 5.8.4.2. IMPFUNG ..................................................................................................................................................... 151 5.9. JAPANISCHE ENZEPHALITIS .......................................................................................................................... 152 5.9.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE ............................................................................................... 152 5.9.2. KRANKHEITSBILD UND DIAGNOSE ..................................................................................................................... 152 5.9.3. THERAPIE ..................................................................................................................................................... 153 5.9.4. PROPHYLAXE.................................................................................................................................................. 153 5.9.4.1 . CHEMOPROPHYLAXE ..................................................................................................................................... 153 5.9.4.2. IMPFUNG ..................................................................................................................................................... 153 12 INHALTSVERZEICHNIS YY IMPFUNGEN IN BESONDEREN SITUATIONEN 154 6.1. FRUEHGEBORENE ........................................................................................................................................... 154 6.2. IMMUNDEFIZIENZ UND ASPLENIE ................................................................................................................. 155 6.3. ALLERGIEN ..................................................................................................................................................... 157 6.4. IMPFEMPFEHLUNGEN FUER MIGRANTEN .......................................................................................................... 158 6.5. COVID-19 ................................................................................................................................................... 159 6.5.1. AETIOLOGIE, PATHOGENESE UND EPIDEMIOLOGIE .............................................................................................. 159 6.5.2. KRANKHEITSBILD UND DIAGNOSE ...................................................................................................................... 160 6.5.3. THERAPIE ...................................................................................................................................................... 161 6.5.3.1 . PROPHYLAXE UND IMPFUNG ............................................................................................................................ 161 YY INDEX 166
any_adam_object	1
author	Heininger, Ulrich 1961-
author_GND	(DE-588)128881313
author_facet	Heininger, Ulrich 1961-
author_role	aut
author_sort	Heininger, Ulrich 1961-
author_variant	u h uh
building	Verbundindex
bvnumber	BV048892626
classification_rvk	XD 3303
ctrlnum	(OCoLC)1369264089 (DE-599)DNB1279632488
dewey-full	614.47
dewey-hundreds	600 - Technology (Applied sciences)
dewey-ones	614 - Forensic medicine; incidence of disease
dewey-raw	614.47
dewey-search	614.47
dewey-sort	3614.47
dewey-tens	610 - Medicine and health
discipline	Medizin
edition	11. Auflage
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02292nam a2200565 c 4500</leader><controlfield tag="001">BV048892626</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240219 </controlfield><controlfield tag="007">t\|</controlfield><controlfield tag="008">230406s2022 gw a\|\|\| \|\|\|\| 00\|\|\| ger d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">23,N06</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">23,A15</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1279632488</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783837416411</subfield><subfield code="c">Festeinband : EUR 39.80 (DE), EUR 41.00 (AT), CHF 66.00 (freier Preis)</subfield><subfield code="9">978-3-8374-1641-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3837416410</subfield><subfield code="9">3-8374-1641-0</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783837416411</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1369264089</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1279632488</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-578</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">614.47</subfield><subfield code="2">23/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3303</subfield><subfield code="0">(DE-625)152554:12909</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WA 115</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QW 806</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Heininger, Ulrich</subfield><subfield code="d">1961-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)128881313</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Impfratgeber</subfield><subfield code="b">Impfempfehlungen für Kinder, Jugendliche und Erwachsene : unter Berücksichtigung des Infektionsschutzgesetzes</subfield><subfield code="c">Prof. Dr. Ulrich Heininger</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">11. Auflage</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Bremen ; London</subfield><subfield code="b">UNI-MED Verlag AG</subfield><subfield code="c">[2022]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">170 Seiten</subfield><subfield code="b">Illustrationen, Karten</subfield><subfield code="c">25 cm, 468 g</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">UNI-MED science</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfung</subfield><subfield code="0">(DE-588)4026656-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Impfratgeber</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">STIKO</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Impfungen</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Impfung</subfield><subfield code="0">(DE-588)4026656-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">UNI-MED Verlag AG</subfield><subfield code="0">(DE-588)1065561733</subfield><subfield code="4">pbl</subfield></datafield><datafield tag="780" ind1="0" ind2="0"><subfield code="i">Vorangegangen ist</subfield><subfield code="z">9783837415704</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">X:MVB</subfield><subfield code="q">text/html</subfield><subfield code="u">http://deposit.dnb.de/cgi-bin/dokserv?id=6e8e3031fb4340b69aede87c4ee953a1&prov=M&dok_var=1&dok_ext=htm</subfield><subfield code="3">Inhaltstext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">https://d-nb.info/1279632488/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034157189&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="883" ind1="2" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">dnb</subfield><subfield code="d">20230404</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#dnb</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034157189</subfield></datafield></record></collection>
id	DE-604.BV048892626
illustrated	Illustrated
indexdate	2024-12-20T19:54:57Z
institution	BVB
institution_GND	(DE-588)1065561733
isbn	9783837416411 3837416410
language	German
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-034157189
oclc_num	1369264089
open_access_boolean
owner	DE-578 DE-19 DE-BY-UBM DE-355 DE-BY-UBR
owner_facet	DE-578 DE-19 DE-BY-UBM DE-355 DE-BY-UBR
physical	170 Seiten Illustrationen, Karten 25 cm, 468 g
publishDate	2022
publishDateSearch	2022
publishDateSort	2022
publisher	UNI-MED Verlag AG
record_format	marc
series2	UNI-MED science
spellingShingle	Heininger, Ulrich 1961- Impfratgeber Impfempfehlungen für Kinder, Jugendliche und Erwachsene : unter Berücksichtigung des Infektionsschutzgesetzes Impfung (DE-588)4026656-4 gnd
subject_GND	(DE-588)4026656-4
title	Impfratgeber Impfempfehlungen für Kinder, Jugendliche und Erwachsene : unter Berücksichtigung des Infektionsschutzgesetzes
title_auth	Impfratgeber Impfempfehlungen für Kinder, Jugendliche und Erwachsene : unter Berücksichtigung des Infektionsschutzgesetzes
title_exact_search	Impfratgeber Impfempfehlungen für Kinder, Jugendliche und Erwachsene : unter Berücksichtigung des Infektionsschutzgesetzes
title_full	Impfratgeber Impfempfehlungen für Kinder, Jugendliche und Erwachsene : unter Berücksichtigung des Infektionsschutzgesetzes Prof. Dr. Ulrich Heininger
title_fullStr	Impfratgeber Impfempfehlungen für Kinder, Jugendliche und Erwachsene : unter Berücksichtigung des Infektionsschutzgesetzes Prof. Dr. Ulrich Heininger
title_full_unstemmed	Impfratgeber Impfempfehlungen für Kinder, Jugendliche und Erwachsene : unter Berücksichtigung des Infektionsschutzgesetzes Prof. Dr. Ulrich Heininger
title_short	Impfratgeber
title_sort	impfratgeber impfempfehlungen fur kinder jugendliche und erwachsene unter berucksichtigung des infektionsschutzgesetzes
title_sub	Impfempfehlungen für Kinder, Jugendliche und Erwachsene : unter Berücksichtigung des Infektionsschutzgesetzes
topic	Impfung (DE-588)4026656-4 gnd
topic_facet	Impfung
url	http://deposit.dnb.de/cgi-bin/dokserv?id=6e8e3031fb4340b69aede87c4ee953a1&prov=M&dok_var=1&dok_ext=htm https://d-nb.info/1279632488/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034157189&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv	AT heiningerulrich impfratgeberimpfempfehlungenfurkinderjugendlicheunderwachseneunterberucksichtigungdesinfektionsschutzgesetzes AT unimedverlagag impfratgeberimpfempfehlungenfurkinderjugendlicheunderwachseneunterberucksichtigungdesinfektionsschutzgesetzes

Verfügbarkeit

‌

Per Fernleihe bestellen Inhaltsverzeichnis